Events
-
-
-
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
Breakthrough in cancer immunotherapy using marine bacteria
A research team led by Professor Eijiro Miyako at the Graduate School of Advanced Science…
Masters of movement: how cancer cells ‘break through’ tight tissue gaps
Aggressive cancer cells are masters of movement. When they spread through the body, they cause…
Rising early-onset colorectal adenomas linked to ultraprocessed food consumption
Emerging evidence from the Nurses’ Health Study II (NHS II) suggests that high intake of…
Theranostics and NETs: Where do we go next?
A new podcast exploring the role of theranostics in neuroendocrine tumours – in celebration of World NET Cancer Day Rachael…
Somatic genome editing therapies are becoming a reality – but debate over ethics, equitable access and governance continue
Olga C. Pandos, University of Adelaide Hundreds of experts from around the world gathered at the Francis Crick Institute in…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.